DK35589D0 - Stabil blanding indeholdende oxidationsfoelsomme forbindelser, fremgangsmaade til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfoelsomme stoffer - Google Patents

Stabil blanding indeholdende oxidationsfoelsomme forbindelser, fremgangsmaade til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfoelsomme stoffer

Info

Publication number
DK35589D0
DK35589D0 DK035589A DK35589A DK35589D0 DK 35589 D0 DK35589 D0 DK 35589D0 DK 035589 A DK035589 A DK 035589A DK 35589 A DK35589 A DK 35589A DK 35589 D0 DK35589 D0 DK 35589D0
Authority
DK
Denmark
Prior art keywords
substances
oxidation sensitive
procedures
preparing
combination
Prior art date
Application number
DK035589A
Other languages
English (en)
Other versions
DK174663B1 (da
DK35589A (da
Inventor
Chiharu Fukamachi
Horst Schumacher
Wolfgang Bewert
Joachim Schneider
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of DK35589D0 publication Critical patent/DK35589D0/da
Publication of DK35589A publication Critical patent/DK35589A/da
Application granted granted Critical
Publication of DK174663B1 publication Critical patent/DK174663B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
DK198900355A 1988-01-29 1989-01-27 Stabil blanding indeholdende oxidationsfølsomme forbindelser, fremgangsmåde til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfølsomme forbindelser DK174663B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1723288 1988-01-29
JP1723288 1988-01-29

Publications (3)

Publication Number Publication Date
DK35589D0 true DK35589D0 (da) 1989-01-27
DK35589A DK35589A (da) 1989-07-30
DK174663B1 DK174663B1 (da) 2003-08-18

Family

ID=11938201

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900355A DK174663B1 (da) 1988-01-29 1989-01-27 Stabil blanding indeholdende oxidationsfølsomme forbindelser, fremgangsmåde til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfølsomme forbindelser

Country Status (10)

Country Link
US (1) US4929774A (da)
EP (1) EP0326026B1 (da)
KR (1) KR890011974A (da)
CN (1) CN1023229C (da)
CA (1) CA1331136C (da)
DE (1) DE58901641D1 (da)
DK (1) DK174663B1 (da)
IL (1) IL88961A (da)
IN (1) IN171845B (da)
SU (1) SU1639425A3 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
JPH02124894A (ja) * 1988-11-01 1990-05-14 Sanwa Kagaku Kenkyusho Co Ltd フィチン酸安定化組成物
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
ES2221921T3 (es) * 1992-07-13 2005-01-16 Shiseido Company, Ltd. Composicion para preparacion dermatologica.
US5270063A (en) * 1992-08-03 1993-12-14 Kellogg Company Ready-to-eat cereal products enriched with beta-carotene
FR2703263B1 (fr) * 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH07203950A (ja) * 1994-01-26 1995-08-08 Kanegafuchi Chem Ind Co Ltd 被覆されたファフィア・ロドチーマ酵母及びその造粒物
AUPM677594A0 (en) * 1994-07-12 1994-08-04 Daratech Pty Ltd Preservation of exposed underground plant structures
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
CA2217264A1 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
DE19518845A1 (de) * 1995-05-23 1996-11-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure
US5827904A (en) * 1996-09-27 1998-10-27 Hahn; David Medical implant composition
JP2002513411A (ja) 1997-04-04 2002-05-08 ヘンケル コーポレーション 高いバイオアベイラビリティを有するルテインエステル
US6007856A (en) * 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
AU2753100A (en) 1999-02-03 2000-08-25 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
US6689400B2 (en) * 2001-01-30 2004-02-10 Sabinsa Corporation Process of obtaining compositions of stable lutein and lutein derivatives
US20060062855A1 (en) * 2001-02-27 2006-03-23 Bell Steve J D Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US20060110517A1 (en) 2003-01-31 2006-05-25 Reinhold Carle Novel compositions comprising carotenoids
DE10311585A1 (de) 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
DE10325989A1 (de) * 2003-06-07 2005-01-05 Glatt Gmbh Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
US7446101B1 (en) * 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
PL1729797T3 (pl) 2004-03-22 2009-02-27 Abbott Laboratories Gmbh Doustne kompozycje farmaceutyczne produktów zawierających lipazę, a zwłaszcza pankreatynę, zawierające środki powierzchniowo czynne
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
WO2006011592A1 (ja) * 2004-07-30 2006-02-02 Wakunaga Pharmaceutical Co., Ltd. カプセル皮膜用組成物、カプセル皮膜、及びこれを用いたカプセル剤
JP2008518956A (ja) 2004-11-01 2008-06-05 バイオサンテ ファーマシューティカルズ，インコーポレイティド 化粧又は美容薬品のための使用における治療用リン酸カルシウム、及び製造方法、及び使用
CN101233229B (zh) 2005-07-29 2013-05-01 雅培实验室有限公司 制备消毒的胰酶粉末的方法
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EP3432730B1 (de) * 2016-03-24 2023-11-08 Basf Se Mehrphasige wirkstoffzubereitungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5614338B2 (da) * 1973-05-31 1981-04-03
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
JPS59122424A (ja) * 1982-12-29 1984-07-14 Riken Vitamin Co Ltd ビタミンａ組成物およびその製造法
JPS59204696A (ja) * 1983-05-06 1984-11-20 三井製薬工業株式会社 酸化防止剤
JPS62111676A (ja) * 1985-11-12 1987-05-22 Nippon Oil & Fats Co Ltd 酸化防止製剤

Also Published As

Publication number Publication date
IL88961A (en) 1992-07-15
CN1023229C (zh) 1993-12-22
KR890011974A (ko) 1989-08-23
IL88961A0 (en) 1989-08-15
CA1331136C (en) 1994-08-02
EP0326026B1 (de) 1992-06-17
DE58901641D1 (de) 1992-07-23
EP0326026A2 (de) 1989-08-02
EP0326026A3 (en) 1990-11-14
DK174663B1 (da) 2003-08-18
SU1639425A3 (ru) 1991-03-30
DK35589A (da) 1989-07-30
US4929774A (en) 1990-05-29
IN171845B (da) 1993-01-23
CN1036220A (zh) 1989-10-11

Similar Documents

Publication Publication Date Title
DK35589D0 (da) Stabil blanding indeholdende oxidationsfoelsomme forbindelser, fremgangsmaade til fremstilling heraf og anvendelse af en kombination af stoffer til stabilisering af oxidationsfoelsomme stoffer
DK101288D0 (da) Lagdelt chalcogenidmateriale, katalysator indeholdende dette samt fremgangsmaade til fremstilling af dette
DK162518C (da) Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne
DK272587D0 (da) Stabiliserede praeparater, der indeholder flere vitaminer og sporgrundstoffer
DK340785A (da) Quinonderivater, fremgangsmaade til fremstilling af dem og farmaceutisk praeparat indeholdende dem
DK368387A (da) Stabilt farmaceutisk praeparat indeholdende granulocytkolonistimulerende faktor og fremgangsmaade til fremstilling af dette
DK183589D0 (da) Farmaceutisk middel indeholdende en 12-leddet macrolid-forbindelse og fremgangsmaade til fremstilling heraf
NO894999D0 (no) Antiseptiske blandinger inneholdende heksahydro-5-pyrimidinaminforbindelser og thymol og fremgangsmaater for fremstilling derav.
DK106989D0 (da) Isoindolinonderivat, fremgangsmaade til fremstilling af dette, og laegemiddel indeholdende dette
DK4189D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende og fremgangsmaade til fremstilling af forbindelsen
DK127588A (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK218985A (da) Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem
IL57847A0 (en) Adducts of k vitaminic compounds and stabilizing vitamins,preparation thereof and stabilized adducts thus provided
DK565288D0 (da) Fremgangsmaade til fremstilling af triglycerider, anvendelse af saadanne triglycerider og en emulsion, der indeholder saadanne triglycerider
DK166088C (da) 2'-deoxy-5-fluoruridinderivater, fremgangsmaade til fremstilling deraf, anticancermidler indeholdende saadanne forbindelser og anvendelse af saadanne forbindelser til fremstilling af anticancermidler
DK36588A (da) 5-oxy derivater af tetrahydrofuran, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK340388A (da) Aminocyklopentylaetere, fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DK187989A (da) Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser
DK262286D0 (da) Fenantrenderivater, fremgangsmaade til fremstilling deraf og fungicide praeparater indeholdende saadanne forbindelser
DK612788D0 (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK419186A (da) Stabiliseret hydrogenperoxidoploesning og fremgangsmaade til fremstilling deraf
DK81287A (da) 2-cyanobenzimidazolderivater, fremgangsmaade til fremstilling deraf og kombinations-fungicidpraeparater indeholdende saadanne forbindelser
DK597184D0 (da) Substituerede spiro-pyridinderivater, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af saadanne forbindelser
DK536282A (da) Fremgangsmaade til adskillelse af blandinger af insulin, insulinderivater og eventuelt urenheder
DK525187D0 (da) Imidazooe4,5-baapyridinon-2-derivater, fremgangsmaade til fremstilling af og laegemidler indeholdende saadanne derivater

Legal Events

Date Code Title Description
PUP Patent expired